Feature | December 09, 2013

ACC Helps Hospitals, Patients Avoid Readmissions

Navigator program brings team approach to meeting patient needs, reducing rehospitalization

December 9, 2013 — With increased penalties in effect for hospitals with excessive readmissions for heart attack and heart failure, the American College of Cardiology (ACC) is launching a program that applies a team approach to keeping patients at home and healthy after discharge.
 
The ACC created the Patient Navigator Program to support a team of caregivers at selected hospitals to help patients overcome challenges during their hospital stay and in the weeks following discharge when they are at most risk for readmission. Hospitals have been given funding to establish a program that supports a culture of patient-centered care that can potentially be implemented in other hospitals in the future. AstraZeneca is the founding sponsor of the ACC Patient Navigator Program.
 
“The ACC Patient Navigator Program will serve as a test for innovative, patient-centered solutions to address issues that impact patient health and patient readmissions,” said John Harold, M.D., MACC, and president, ACC. “These hospitals will serve as pioneers in a new approach to heart disease treatment and care that puts emphasis on meeting patients’ ongoing needs and helping patients make a seamless transition from the hospital to the home.”
 
The Centers for Medicare and Medicaid Services increased penalties beginning Oct. 1 for hospitals with excessive readmission rates for heart attack, heart failure and three other non-cardiac conditions within 30 days of discharge. Hospitals could lose up to 2 percent of related Medicare and Medicaid reimbursements, which is double the prior maximum penalty of 1 percent of Medicare payments. Beginning in 2014, the penalty will increase again to a maximum of 3 percent.
 
Nearly one in five patients hospitalized with heart attack and one in four patients hospitalized with heart failure are readmitted within 30 days of discharge, often for conditions seemingly unrelated to the original diagnosis. Readmissions can be related to issues like stresses while in the hospital, fragility on discharge, lack of understanding of discharge instructions and inability to carry out discharge instructions.
 
Out of 132 hospitals initially surveyed about the program, 120 expressed an interest in participating in the first phase of the ACC Patient Navigator Program. Eleven hospitals were chosen for a 2013 program launch, with an additional 24 hospitals slated to join the program by the end of 2015.
 
Listed below are the first 11 participating hospitals, which were chosen because of their commitment to quality demonstrated by participation in the National Cardiovascular Data Registry and Hospital to Home program:
  • Advocate Sherman Hospital, Elgin, Ill.
  • Christiana Care Health Services, Wilmington, Del.
  • Einstein Medical Center Philadelphia, Philadelphia
  • Indiana University Health Methodist Hospital, Indianapolis
  • MedStar Washington Hospital Center, Washington
  • Providence St. Vincent Medical Center, Portland, Ore.
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • St. Mary’s Hospital, Waterbury, Conn.
  • Trident Health, Charleston, S.C.
  • Vanderbilt Heart and Vascular Institute, Nashville, Tenn.
  • WakeMed Health and Hospital, Raleigh, N.C.
 
For more information: www.cardiosource.org

Related Content

Intact Vascular, TOBA clinical study, one-year results, Tack Endovascular System, Journal of Vascular Surgery
News | Peripheral Arterial Disease (PAD)| August 24, 2016
Intact Vascular Inc. announced that the one-year results from its Tack Optimized Balloon Angioplasty (TOBA) clinical...
Technavio report, renal denervation devices, 2015
News | Renal Denervation| August 23, 2016
August 23, 2016 — Technavio analysts forecast the global...
News | Heart Failure| August 23, 2016
August 23, 2016 — A new study of more than 13,000 people has found that so-called morbid obesity appears to stand alo
Jason Burdick, injectable hydrogels, heart failure, heart attack, American Chemical Society

Compared to other types of hydrogels being developed (left), a new hydrogel (right) can form crosslinks after injection into the heart, making the material stiffer and longer-lasting. Image courtesy of American Chemical Society.

News | Heart Failure| August 23, 2016
August 23, 2016 — During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells within
News | Peripheral Arterial Disease (PAD)| August 22, 2016
Avinger Inc. recently announced the closing of its previously announced public offering of 9,857,800 shares of Avinger’...
DMC Heart Hospital, Detroit Medical Center, complex percutaneous intervention education course, PCI, cath lab training
News | Cath Lab| August 22, 2016
The Detroit Medical Center (DMC) Heart Hospital recently completed a Complex Percutaneous Intervention education course...
TAILOR-PCI study, antiplatelet medication, genotype, NHLBI grant
News | Antiplatelet and Anticoagulation Therapies| August 18, 2016
Researchers at the Peter Munk Cardiac Centre, Toronto, and at Mayo Clinic are leading the Tailored Antiplatelet Therapy...
Covidien, Medtronic, TurboHawk, Atherectomy system

The Medtronic TurboHawk atherectomy system. 

Feature | Atherectomy Devices| August 18, 2016 | Dave Fornell
Due to poor outcomes from percutaneous transluminal angioplasty (PTA) ballooning of vessels alone, or of stenting in
Sapien III, Sapien 3, PARTNER III, FDA approval, expanded indication, intermediate risk patients

The Sapien 3 valve has a skirt of fabric at its base that has significantly reduced issues of paravalvular leak, which was an issue with the first generation Sapien device. 

Feature | Heart Valve Technology| August 18, 2016 | Dave Fornell
August 18, 2016 — The U.S.
Corindus Corpath, Acist Medical RXi and CVi, Fairview Southdale Hospital, Minnesota, cath lab
News | Cath Lab| August 17, 2016
Corindus Vascular Robotics Inc. and Acist Medical Systems Inc. are providing Fairview Southdale Hospital, Edina, Minn...
Overlay Init